Biotech

All Articles

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...

Takeda takes $140M loss on fallen short epilepsy medication, promotes FDA run

.We presently understand that Takeda is planning to discover a path to the FDA for epilepsy medicine...

VBI Vaccines files for bankruptcy, finds possession sale

.Immunology biotech VBI Vaccinations is actually drifting dangerously near to the point of no return...

Celldex anti-cKIT antitoxin lessen colonies in one more period 2 research

.It's challenging to muscle mass in on an area as very competitive as immunology, however Celldex Re...

Boehringer offers up to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is actually offering up to $1.3 billion for Nerio Rehabs and a preclinical imm...

Ventyx's last resort for inflammatory med sides in Crohn's failing

.Ventyx Biosciences' Crohn's illness medicine carried out certainly not assist people accomplish rem...

Cognition's phase 2 beam information taint Alzheimer's prospect

.Cognition Therapies' phase 2 SHINE test has taken a few of the appeal off the Alzheimer's health co...

BMS axes bispecific months after filing to function stage 3 trial

.Bristol Myers Squibb has actually had a whiplash change of heart on its BCMA bispecific T-cell enga...

Charles Baum takes over Terremoto as CEO

.Charles Baum, M.D., Ph.D., who managed Mirati Therapies' $ 5.8 billion purchase to Bristol Myers Sq...

Asarina to close after initiatives to companion Tourette's drug fail

.After connecting to greater than 200 companies to companion a Tourette syndrome therapy that presen...